Literature DB >> 23806705

The prevalence of oral Candida infections in periodontitis patients with type 2 diabetes mellitus.

Sultan Al Mubarak1, Asirvatham Alwin Robert, Jagan Kumar Baskaradoss, Khalid Al-Zoman, Abdulaziz Al Sohail, Abdulaziz Alsuwyed, Sebastian Ciancio.   

Abstract

OBJECTIVES: The purpose of this study was to determine the prevalence of Candida spp. in periodontitis patients with type 2 diabetes mellitus.
METHODS: This cross-sectional study included 42 diabetic patients with periodontitis (aged 21-70 years; 18 males and 24 females). Clinical measurements included probing pocket depth (PPD), clinical attachment level (CAL) and hemoglobin A1c (HbA1c) levels. Sub-gingival samples were collected from the mesio-buccal aspect of 3 teeth for fungal analysis. Candida species, including Candida albicans, Candida dubliniensis, Candida tropicalis and Candida glabrata, were identified using Gram staining, the germ tube test, CHROMagar, Staib agar and API 20C AUX.
RESULTS: The overall prevalence of Candida in diabetic patients with periodontitis observed in our study was 52%. The most common spp. of Candida identified were C. albicans (38%), followed by C. dubliniensis (9.5%), C. tropicalis (4.7%) and C. glabrata (4.7%). Compared to females, male patients were characterized by increased levels of Candida infections. Our results also indicate that individuals over the age of 40 had increased levels of Candida infections compared to patients younger than 40. Candida infections were higher among subjects with elevated blood sugar levels (HbA1c>9) compared to individuals with well-controlled blood sugar levels (HbA1c<6). Patients with PPDs≥5 had an increased risk of Candida infection compared to patients with PPDs between 3 and 4.
CONCLUSION: This study indicates that the frequency of C. albicans is higher than the frequencies of C. dubliniensis, C. tropicalis and C. glabrata in diabetic patients with periodontitis. Candida infections were observed at increased frequencies among subjects with high blood sugar levels and PPDs≥5.
Copyright © 2013 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23806705     DOI: 10.1016/j.jiph.2012.12.007

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  14 in total

Review 1.  Diabetes mellitus and oral health.

Authors:  Marina George Kudiyirickal; Joseph M Pappachan
Journal:  Endocrine       Date:  2014-12-09       Impact factor: 3.633

2.  Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.

Authors:  G Vipulanandan; M Herrera; N P Wiederhold; X Li; J Mintz; B L Wickes; D Kadosh
Journal:  J Dent Res       Date:  2017-08-29       Impact factor: 6.116

3.  Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.

Authors:  B Minea; V Nastasa; R F Moraru; A Kolecka; M M Flonta; I Marincu; A Man; F Toma; M Lupse; B Doroftei; N Marangoci; M Pinteala; T Boekhout; M Mares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-16       Impact factor: 3.267

4.  Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - a pilot study.

Authors:  Tomasz Gosiewski; Dominika Salamon; Magdalena Szopa; Agnieszka Sroka; Maciej T Malecki; Malgorzata Bulanda
Journal:  Gut Pathog       Date:  2014-10-15       Impact factor: 4.181

5.  In Vitro Antifungal Activity of Hexahydropyrimidine Derivatives against the Causative Agents of Dermatomycosis.

Authors:  Francislene J Martins; César A Caneschi; Mônica P Senra; Gustavo S G Carvalho; Adilson D da Silva; Nádia R B Raposo
Journal:  ScientificWorldJournal       Date:  2017-10-26

6.  Oral Candidal carriage and associated risk indicators among adults in Sakaka, Saudi Arabia.

Authors:  Saad F Alrayyes; Hammad M Alruwaili; Ibrahim A Taher; Khaled M Elrahawy; Abdulrahman H Almaeen; Awad O Ashekhi; Mohammad Khursheed Alam
Journal:  BMC Oral Health       Date:  2019-05-22       Impact factor: 2.757

7.  Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects.

Authors:  Sanja Matic Petrovic; Milena Radunovic; Milena Barac; Jovana Kuzmanovic Pficer; Dusan Pavlica; Valentina Arsic Arsenijevic; Ana Pucar
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

8.  Potential Pathogenicity of Candida Species Isolated from Oral Cavity of Patients with Diabetes Mellitus.

Authors:  Hasti Nouraei; Mehdi Ghaderian Jahromi; Leila Razeghian Jahromi; Kamiar Zomorodian; Keyvan Pakshir
Journal:  Biomed Res Int       Date:  2021-05-26       Impact factor: 3.411

9.  Changes in serum inflammatory factor interleukin-6 levels and pathology of carotid vessel walls of rats with chronic periodontitis and diabetes mellitus after the periodontal intervention.

Authors:  Danjun Chen; Liangjun Zhong; Yuan Li; Rui He; Cheng Ding; Xing Chen; Wenhai Lian
Journal:  Saudi J Biol Sci       Date:  2020-04-23       Impact factor: 4.219

Review 10.  The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.

Authors:  Gholamreza Daryabor; Mohamad Reza Atashzar; Dieter Kabelitz; Seppo Meri; Kurosh Kalantar
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.